FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Draft Guide on Generic Drug User Fees

Federal Register notice: FDA makes available a draft guidance entitled Assessing User Fees under the Generic Drug User Fee Amendments of 2017.

FDA General

Trump Taps MD Andersons Hahn as FDA Head

President Donald Trump chooses to nominate MD Anderson chief medical officer Stephen Hahn to be FDA commissioner.

Federal Register

Panel to Review Correvio Atrial Fibrillation Drug

Federal Register notice: FDA has announced a 12/10 Cardiovascular and Renal Drugs Advisory Committee meeting to discuss a Correvio International NDA f...

Human Drugs

Novartis Trial Misses Superiority in Cosentyx Trial

Novartis says its EXCEED head-to-head trial comparing Cosentyx (secukinumab) to AbbVies Humira (adalimumab) in patients with active psoriatic arthriti...

Human Drugs

NDMA Testing on Ranitidine Better Than First Thought: FDA

An FDA update on an ongoing investigation about a contaminant known as N-Nitrosodimethylamine found in ranitidine (Zantac) says that preliminary testi...

Medical Devices

Xact Robotics Percutaneous Interventional Device Cleared

FDA clears an Xact Robotics 510(k) for its robotic system and its use during computed tomography guided percutaneous interventional procedures.

Medical Devices

Thoratec Recalls CentriMag Systems

Thoratec Switzerland recalls its CentriMag Acute Circulatory Support System Motor, which is a component of the CentriMag Extracorporeal Blood Pumping ...

Federal Register

Mexitil Not Withdrawn Over Safety/Efficacy: FDA

Federal Register notice: FDA determines that Boehringer Ingelheims Mexitil (mexiletine hydrochloride) was not withdrawn from sale for safety or effect...

Medical Devices

Stryker Sahara Lateral 3D Spine Implant Cleared

FDA clears a Stryker 510(k) for its Sahara Lateral 3D Expandable Interbody System featuring Lamellar 3D Titanium Technology.

Medical Devices

Senators Have More Software Pre-Cert Questions

Sens. Warren, Murray, and Smith raise 18 additional questions for FDA to answer on its software pre-certification program.